Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article suggesting that mitochondria are the main targets of PD-1 inhibitory activity. PD-1 reprograms CD8 + T cell metabolism for efficient use of fatty acid oxidation; this mitochondrial phenotype might explain the...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a short report discussing the role of B cells in the anti-tumor activity of PD-1 inhibitors and their activity in mouse models receiving B cell depleting drugs or with immunoglobulin deficiencies. Authors: William Damsky , Lucia...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article demonstrating that high numbers of peripheral CD8 T cells expressing differentiation markers and lacking co-stimulatory receptors at baseline are associated with response to nivolumab in NSCLC patients. Authors: ...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article providing evidence for co-expression of multiple immune checkpoint genes including, PD-1 , PD-L1, IDO1, TIGIT, TIM-3, TGFB1, LAG3, and others, that potentially contribute to compensatory immune evasion in...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report discussing immuno-PET studies of PD-L1 in a preclinical tumorgraft model of clear cell RCC (ccRCC) from a patient who had a favorable response to anti-PD-1 therapy. Authors: Joseph Vento , Aditi Mulgaonkar , ...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report describing a patient with myasthenia gravis treated with pembrolizumab demonstrating successful outcomes. Authors: Anne Zaremba , Eleftheria Chorti , Finja Jockenhöfer , Saskia Bolz , Selma Sirin , Martin Glas ,...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article supporting the development of D2C7-IT and immune checkpoint blockade combinations for patients with malignant glioma. Authors: Vidyalakshmi Chandramohan, Xuhui Bao , Xin Yu , Scott Parker , Charlotte...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article in which a listeria vaccine-based immunotherapy was shown to be able to induce a tumor antigen-specific T cell response within the tumor microenvironment of a “cold” tumor such as PDAC and sensitize the tumor to...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article concluding that ICIs produce a spectrum of distinct classes of neurologic AEs that can cause significant morbidity and mortality and tend to occur early and with class-specific associations. Authors: Douglas B....
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a position article and guidelines. This paper defines ways in which treatment with I-O is different from other therapies. It also proposes key aspects and attributes of I-O therapies that should be considered in any assessment of...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us